CHRNA7 and early-onset autosomal dominant Alzheimer disease: Besides, studies from other labs also found that activation of α7nAChR is beneficial to many central nervous system diseases such as Alzheimer’s disease, schizophrenia, and stroke (Han et al., 2014a; Dineley et al., 2015; Nakaizumi et al., 2018).